Tesi’s portfolio company: TILT Biotherapeutics

Suomeksi

Search for

For companies
For investors
Investments
- Investments
- Companies
- Funds
- Cases
Team
News
Market data
Sustainability
About Tesi

HomeCompaniesTILT Biotherapeutics Oy

tiltbio.com

Portfolio
Venture Capital Investments

Industry
Health & Life Science

Manager
Miia Kaye

Investment Year
2022

TILT Biotherapeutics is a biotechnology company that develops cancer immunotherapies, or, trying to harness body’s own immune system against the cancer cells.

News
14.6.2022

TILT Biotherapeutics announces EUR 10 million financing to advance immuno-oncology studies

Case
16.8.2024

TILT Biotherapeutics – More effective therapies to treat cancer

* indicates required

Email Address *

First Name

Last Name

How often would you like to hear from us? *

Daily, if there is new content
Once a week
Once a month

Marketing Permissions *

By accepting this form, you give Tesi and the partners who produce its newsletter permission to process your information with the newsletters. You can unsubscribe at any time by clicking the link in the footer of our emails or by contacting info@tesi.fi For information about our privacy practices, please visit our website https://www.tesi.fi/en/privacy-policy/.

Grow Together.

Tesi (Finnish Industry Investment Ltd)
Porkkalankatu 1, 00180 Helsinki